Author Contributions: Dr Kroenke had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Kroenke, Theobald, Carpenter, Morrison
Acquisition of data: Kroenke, Theobald, Norton
Analysis and interpretation of data: Kroenke, Wu, Tu, Theobald, Carpenter, Morrison,
Drafting of the manuscript: Kroenke, Wu, Tu
Critical revision of the manuscript for important intellectual content: Kroenke, Wu, Tu, Theobald, Carpenter, Morrison, Norton
Statistical analysis: Kroenke, Wu, Tu.
Obtained funding: Kroenke.
Administrative, technical, or material support: Kroenke, Theobald, Norton
Study supervision: Kroenke, Theobald, Norton
Financial Disclosures: Dr Kroenke reported receiving research funding from Eli Lilly and Pfizer, and honoraria as a speaker, consultant, or advisory board member from Eli Lilly, Pfizer, and Forest Laboratories. No other authors reported disclosures.
Funding/Support: This study was supported by grant R01 CA-115369 from the National Cancer Institute (Dr Kroenke).
Role of the Sponsor: The sponsor provided financial support for the study only and had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Additional Contributions: We gratefully thank nurse care management provided by Becky Sanders, RN, and Susan Schlundt, RN, and the research assistance provided by Stephanie McCalley, BA, and Pam Harvey, BA. These individuals were compensated as study personnel.